159
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The κ-Opioid Receptor Agonist U50488H Ameliorates Neuropathic Pain Through the Ca2+/CaMKII/CREB Pathway in Rats

, , , &
Pages 3039-3051 | Published online: 23 May 2022

References

  • Jay GW, Barkin RL. Neuropathic pain: etiology, pathophysiology, mechanisms, and evaluations. Dis Mon. 2014;60(1):6–47. doi:10.1016/j.disamonth.2013.12.001
  • Noor S, Sanchez JJ, Vanderwall AG, et al. Prenatal alcohol exposure potentiates chronic neuropathic pain, spinal glial and immune cell activation and alters sciatic nerve and DRG cytokine levels. Brain Behav Immun. 2017;61:80–95. doi:10.1016/j.bbi.2016.12.016
  • Liou JT, Lee CM, Lin YC, et al. P-selectin is required for neutrophils and macrophage infiltration into injured site and contributes to generation of behavioral hypersensitivity following peripheral nerve injury in mice. Pain. 1994;154(10): 2150–2159.
  • Janzadeh A, Karami Z, Hosseini M, Zarepour L, Yousefifard M, Nasirinezhad F. The role of CGRP receptor antagonist (CGRP8-37) and Endomorphin-1 combination therapy on neuropathic pain alleviation and expression of Sigma-1 receptors and antioxidants in rats. J Chem Neuroanat. 2020;106:101771. doi:10.1016/j.jchemneu.2020.101771
  • Chen J, Li L, Chen SR, et al. The alpha2delta-1-NMDA receptor complex is critically involved in neuropathic pain development and gabapentin therapeutic actions. Cell Rep. 2018;22(9):2307–2321. doi:10.1016/j.celrep.2018.02.021
  • Liu-Chen LY. Agonist-induced regulation and trafficking of kappa opioid receptors. Life Sci. 2004;75(5):511–536. doi:10.1016/j.lfs.2003.10.041
  • Buesa I, Urrutia A, Aira Z, et al. Depression of C fibre-evoked spinal field potentials by the spinal delta opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: involvement of the mu-subtype. Neuropharmacology. 2008;55(8):1376–1382.
  • Puryear CB, Brooks J, Tan L, et al. Opioid receptor modulation of neural circuits in depression: what can be learned from preclinical data? Neurosci Biobehav Rev. 2020;108:658–678. doi:10.1016/j.neubiorev.2019.12.007
  • Paton KF, Atigari DV, Kaska S, Prisinzano T, Kivell BM. Strategies for developing kappa opioid receptor agonists for the treatment of pain with fewer side effects. J Pharmacol Exp Ther. 2020;375:332–348. doi:10.1124/jpet.120.000134
  • Yang Y, Wen J, Zheng B, et al. CREB participates in paclitaxel-induced neuropathic pain genesis through transcriptional activation of Dnmt3a in primary sensory neurons. Neurotherapeutics. 2021;18:586–600. doi:10.1007/s13311-020-00931-5
  • Song X, Cui Z, He J, Yang T, Sun X. kappa‑opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca(2+)/CaMKII/CREB signaling pathway and improves synaptic plasticity in APP/PS1 mice. Mol Med Rep. 2021;24:1–9.
  • Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000;87:149–158. doi:10.1016/S0304-3959(00)00276-1
  • Gugliandolo E, D’Amico R, Cordaro M, et al. Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush. J Neuroinflammation. 2018;15:264. doi:10.1186/s12974-018-1303-5
  • Ban EG, Brassai A, Vizi ES. The role of the endogenous neurotransmitters associated with neuropathic pain and in the opioid crisis: the innate pain-relieving system. Brain Res Bull. 2020;155:129–136.
  • Sharma K, Sharma D, Sharma M, et al. Astaxanthin ameliorates behavioral and biochemical alterations in in-vitro and in-vivo model of neuropathic pain. Neurosci Lett. 2018;674:162–170. doi:10.1016/j.neulet.2018.03.030
  • Uniyal A, Shantanu PA, Vaidya S, et al. Tozasertib attenuates neuropathic pain by interfering with aurora kinase and KIF11 mediated nociception. ACS Chem Neurosci. 2021;12:1948–1960. doi:10.1021/acschemneuro.1c00043
  • Vaidya S, Shantanu PA, Tiwari V. Attenuation of ongoing neuropathic pain by peripheral acting opioid involves activation of central dopaminergic neurocircuitry. Neurosci Lett. 2021;754:135751. doi:10.1016/j.neulet.2021.135751
  • Kumru H, Benito-Penalva J, Kofler M, Vidal J. Analgesic effect of intrathecal baclofen bolus on neuropathic pain in spinal cord injury patients. Brain Res Bull. 2018;140:205–211.
  • Woller SA, Hook MA. Opioid administration following spinal cord injury: implications for pain and locomotor recovery. Exp Neurol. 2013;247:328–341.
  • Ban EG, Brassai A, Vizi ES. The role of the endogenous neurotransmitters associated with neuropathic pain and in the opioid crisis: the innate pain-relieving system. Brain Res Bull. 2020;155:129–136.
  • Woller SA, Hook MA. Opioid administration following spinal cord injury: implications for pain and locomotor recovery. Exp Neurol. 2013;247:328–341.
  • Hu JY, Li CL, Wang YW. Intrathecal administration of triptolide, a T lymphocyte inhibitor, attenuates chronic constriction injury-induced neuropathic pain in rats. Brain Res. 2012;1436:122–129. doi:10.1016/j.brainres.2011.11.051
  • Rezaee L, Manaheji H, Haghparast A. Role of spinal glial cells in excitability of wide dynamic range neurons and the development of neuropathic pain with the L5 spinal nerve transection in the rats: behavioral and electrophysiological study. Physiol Behav. 2019;209:112597. doi:10.1016/j.physbeh.2019.112597
  • He L, Han G, Wu S, et al. Toll-like receptor 7 contributes to neuropathic pain by activating NF-kappaB in primary sensory neurons. Brain Behav Immun. 2020;87:840
  • Kusuda R, Ravanelli MI, Cadetti F, et al. Long-term antidepressant treatment inhibits neuropathic pain-induced CREB and PLCgamma-1 phosphorylation in the mouse spinal cord dorsal horn. J Pain. 2013;14(10):1162–1172. doi:10.1016/j.jpain.2013.04.015